Emerging evidence suggests that HDL function is not always accurately predicted by HDL
choles-terol levels. The functions of HDL include reverse cholesterol transport and …

HDL is known to be inversely correlated with cardiovascular disease due to its diverse
antiatherogenic functions. These functions include cholesterol efflux and reverse cholesterol …

It is well known that, in large populations, HDL-cholesterol levels are inversely related to the
risk of atherosclerotic clinical events; however, in an individual, the predictive value of an …

A low plasma level of HDL cholesterol is an atherosclerotic risk factor; however, emerging
evidence suggests that low HDL levels might also contribute to the pathophysiology of type …

Low high-density lipoprotein cholesterol (HDL-C) characterizes an atherogenic dyslipidemia
that reflects adverse lifestyle choices, impaired metabolism, and increased cardiovascular …

For decades, HDL and HDL-cholesterol (HDL-C) levels were viewed as synonymous, and
modulation of HDL-C levels by drug therapy held great promise for the prevention and …

HDL is a complex macromolecular cluster of various components, such as apolipoproteins,
enzymes and lipids. Quality evidence from clinical and epidemiological studies led to the …

This review aims to provide an overview on the properties of high‐density lipoproteins
(HDLs) and their cardioprotective effects. Emergent HDL therapies will be presented in the …

Coronary artery disease, the leading cause of death in the developed and developing
countries, is prevalent in diabetes mellitus with 68% cardiovascular disease (CVD)-related …

Low levels of HDL cholesterol are a significant predictor of atherosclerotic cardiovascular
events. HDL is believed to protect against atherosclerosis by promoting reverse cholesterol …